Uncategorized Phage cocktail, AP-PA02, safely lowers P. aeruginosa load 10 Mar 2023 Potential efficacy also reported supports company plans for Phase 2b study AP-PA02, an experimental phage therapy for people with cystic fibrosis (CF) and chronic Pseudomonas aeruginosa respiratory infections, was well tolerated and reduced the bacterial load in…